1. Home
  2. ENZ vs PYPD Comparison

ENZ vs PYPD Comparison

Compare ENZ & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENZ
  • PYPD
  • Stock Information
  • Founded
  • ENZ 1976
  • PYPD 2008
  • Country
  • ENZ United States
  • PYPD Israel
  • Employees
  • ENZ N/A
  • PYPD N/A
  • Industry
  • ENZ Medical Specialities
  • PYPD Medical/Dental Instruments
  • Sector
  • ENZ Health Care
  • PYPD Health Care
  • Exchange
  • ENZ Nasdaq
  • PYPD Nasdaq
  • Market Cap
  • ENZ 34.2M
  • PYPD 29.1M
  • IPO Year
  • ENZ N/A
  • PYPD 2020
  • Fundamental
  • Price
  • ENZ $0.56
  • PYPD $2.99
  • Analyst Decision
  • ENZ
  • PYPD Strong Buy
  • Analyst Count
  • ENZ 0
  • PYPD 2
  • Target Price
  • ENZ N/A
  • PYPD $10.50
  • AVG Volume (30 Days)
  • ENZ 125.9K
  • PYPD 26.8K
  • Earning Date
  • ENZ 03-12-2025
  • PYPD 02-12-2025
  • Dividend Yield
  • ENZ N/A
  • PYPD N/A
  • EPS Growth
  • ENZ N/A
  • PYPD N/A
  • EPS
  • ENZ N/A
  • PYPD N/A
  • Revenue
  • ENZ $30,314,000.00
  • PYPD N/A
  • Revenue This Year
  • ENZ N/A
  • PYPD N/A
  • Revenue Next Year
  • ENZ N/A
  • PYPD N/A
  • P/E Ratio
  • ENZ N/A
  • PYPD N/A
  • Revenue Growth
  • ENZ N/A
  • PYPD N/A
  • 52 Week Low
  • ENZ $0.54
  • PYPD $2.37
  • 52 Week High
  • ENZ $1.40
  • PYPD $7.00
  • Technical
  • Relative Strength Index (RSI)
  • ENZ 28.08
  • PYPD 44.51
  • Support Level
  • ENZ $0.56
  • PYPD $2.88
  • Resistance Level
  • ENZ $0.69
  • PYPD $3.48
  • Average True Range (ATR)
  • ENZ 0.03
  • PYPD 0.28
  • MACD
  • ENZ 0.00
  • PYPD -0.02
  • Stochastic Oscillator
  • ENZ 11.54
  • PYPD 19.58

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: